Why digital innovation matters more than ever

Life sciences is entering a pivotal period where digital innovation, data‑driven decision‑making and patient‑centred technologies are no longer optional - they are essential for sustainable success.

Organisations face increasing pressure to modernise, managing AI adoption, rising data complexity and tougher regulatory expectations at a pace never seen before.

This industry report features industry-led insights into the forces accelerating digital change in Life Sciences and the challenges leaders must respond to.

Take a look inside the report:

Regulatory and Compliance Challenges

Why regulation is becoming a strategic lever, and how leaders are using digital tools to manage complexity, build trust and enable innovation at pace.

Patient‑centred Technology

Exploring the shift towards outcome‑driven, patient‑first technologies and what it takes to design digital solutions that deliver real‑world impact.

AI and Data

A practical look at how data and AI is being applied today and outlining where value is actually being realised.

The Digital Transformation of Life Sciences

How organisations are moving beyond isolated initiatives to embed digital capability into core operating models.

 The Road Ahead

Key themes shaping the future of Life Sciences, and the priorities leaders should focus on as digital maturity becomes a competitive differentiator.

Download the report here

Meet the contributors

Tarn Brown

Life Sciences Industry Lead at Columbus Global

Shaping value‑led digital transformation for life sciences organisations, designing compliant, phased roadmaps that align people, capability, and data integrity with measurable outcomes.

Massimo Crudeli

Director of Client Solutions at STAEDEAN

Trusted advisor in life sciences ERP and supply chain transformation, specialising in compliant, global system implementations across pharma and medical devices.

Chris Reid

Head of Digital Quality CoE at ProductLife Group

Global authority on digital quality and IT compliance, supporting life sciences organisations to adopt innovative technologies while maintaining GxP and data integrity.

Magnus Oxenwaldt

VP Group AI at Columbus Global

Driving AI strategy at Columbus Global and accelerating time-to-value for clients through AI-enhanced solutions.

Divya Vijay Pratheek

Vice President of Product and Marketing at Ribbon Bio

Biotechnology product leader shaping the future of synthetic DNA manufacturing, combining deep life sciences expertise with a focus on scalable, high‑precision production platforms.

Daniel Garner

Director of IT at Dental Directory Group

Leading digital and operational modernisation across one of the UK’s largest healthcare distribution networks, aligning technology, security, and supply chain systems to support regulated growth.

Gareth Willis

CEO and Co-founder of Exosla Therapeutics

Leading Exosla Therapeutics in developing scalable extracellular‑vesicle‑based immunotherapies, bridging translational science and next‑generation biologics manufacturing.

Stephanie Schorge

Head of Research Department at UCL

Advancing translational neuroscience research at UCL, driving academic–industry collaboration to advance neurological therapies from discovery to clinical impact.

Professor Alejandro Frangi

Bicentenary Turing Chair in Computation Sciences at The University of Manchester

World‑leading authority in computational medicine, advancing AI‑driven in‑silico trials and digital twins to transform how medical products are developed and regulated.